Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 434 entries
View as:

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003846 Org: User:
Start: 07/31/99 End: 03/31/07 Due: 03/31/08

Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01146210 Org: User:
Start: 05/31/09 End: 05/31/16 Due: 05/31/17

Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003291 Org: User:
Start: 03/31/98 End: - Due: -

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01790152 Org: User:
Start: 03/05/14 End: 12/31/25 Due: 12/31/26

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05705531 Org: User:
Start: 08/18/23 End: 10/01/28 Due: 10/01/29

Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00003935 Org: User:
Start: 09/30/99 End: 03/31/07 Due: 03/31/08

Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01876303 Org: User:
Start: 12/31/12 End: - Due: -

Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00047320 Org: User:
Start: 01/31/04 End: 02/28/09 Due: 02/28/10

Gene Analysis in Studying Susceptibility to Wilms Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01808079 Org: User:
Start: 10/31/09 End: 11/30/09 Due: 11/30/10

Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01520233 Org: User:
Start: 01/31/12 End: 05/31/16 Due: 05/31/17

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04195399 Org: User:
Start: 10/07/20 End: 06/30/25 Due: 06/30/26

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01817075 Org: User:
Start: 11/04/13 End: 03/31/20 Due: 03/31/21

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00005603 Org: User:
Start: 03/31/00 End: - Due: -

Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01419496 Org: User:
Start: 09/30/11 End: - Due: -

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT00890435 Org: User:
Start: 07/31/08 End: 01/31/11 Due: 01/31/12

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Phase: N/A Priority: Normal
NCT ID: NCT03792256 Org: User:
Start: 04/11/19 End: 09/30/23 Due: 09/30/24

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01510600 Org: User:
Start: 01/31/12 End: 05/31/16 Due: 05/31/17

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01793233 Org: User:
Start: 06/17/13 End: 06/30/24 Due: 06/30/25

Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01438138 Org: User:
Start: 09/30/11 End: 05/31/16 Due: 05/31/17

Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01146223 Org: User:
Start: 09/30/09 End: 06/30/11 Due: 06/30/12

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01334515 Org: User:
Start: 09/30/11 End: 09/30/19 Due: 09/30/20

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00674193 Org: User:
Start: 02/29/08 End: - Due: -

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

Phase: N/A Priority: Normal
NCT ID: NCT00008424 Org: User:
Start: 10/31/00 End: 09/30/06 Due: 09/30/07

Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00335738 Org: User:
Start: 12/31/05 End: 09/30/20 Due: 09/30/21

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03067181 Org: User:
Start: 05/25/17 End: 06/30/27 Due: 06/30/28